183 related articles for article (PubMed ID: 22477710)
1. Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.
Talieri M; Zoma M; Devetzi M; Scorilas A; Ardavanis A
Tumour Biol; 2012 Oct; 33(5):1375-83. PubMed ID: 22477710
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma.
Vakrakou A; Devetzi M; Papachristopoulou G; Malachias A; Scorilas A; Xynopoulos D; Talieri M
Biol Chem; 2014 Sep; 395(9):1105-17. PubMed ID: 25153391
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.
Christodoulou S; Alexopoulou DK; Kontos CK; Scorilas A; Papadopoulos IN
Tumour Biol; 2014 May; 35(5):4673-85. PubMed ID: 24430362
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
[TBL] [Abstract][Full Text] [Related]
6. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
Ahmed N; Dorn J; Napieralski R; Drecoll E; Kotzsch M; Goettig P; Zein E; Avril S; Kiechle M; Diamandis EP; Schmitt M; Magdolen V
Biol Chem; 2016 Dec; 397(12):1265-1276. PubMed ID: 27483364
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.
Seiz L; Dorn J; Kotzsch M; Walch A; Grebenchtchikov NI; Gkazepis A; Schmalfeldt B; Kiechle M; Bayani J; Diamandis EP; Langer R; Sweep FC; Schmitt M; Magdolen V
Biol Chem; 2012 Apr; 393(5):391-401. PubMed ID: 22505521
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
Drucker KL; Paulsen AR; Giannini C; Decker PA; Blaber SI; Blaber M; Uhm JH; O'Neill BP; Jenkins RB; Scarisbrick IA
Neuro Oncol; 2013 Mar; 15(3):305-18. PubMed ID: 23307575
[TBL] [Abstract][Full Text] [Related]
12. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Talieri M; Alexopoulou DK; Scorilas A; Kypraios D; Arnogiannaki N; Devetzi M; Patsavela M; Xynopoulos D
Tumour Biol; 2011 Aug; 32(4):737-44. PubMed ID: 21487810
[TBL] [Abstract][Full Text] [Related]
14. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.
Kim JJ; Kim JT; Yoon HR; Kang MA; Kim JH; Lee YH; Kim JW; Lee SJ; Song EY; Myung PK; Lee HG
Tumour Biol; 2012 Jun; 33(3):731-8. PubMed ID: 22373580
[TBL] [Abstract][Full Text] [Related]
15. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A
Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
17. Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence.
Papachristopoulou G; Malachias A; Devetzi M; Kamouza E; Scorilas A; Xynopoulos D; Talieri M
Clin Chem Lab Med; 2019 Jul; 57(8):1251-1260. PubMed ID: 30759066
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Kountourakis P; Psyrri A; Scorilas A; Camp R; Markakis S; Kowalski D; Diamandis EP; Dimopoulos MA
Cancer Sci; 2008 Nov; 99(11):2224-9. PubMed ID: 18957059
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.
Gong W; Liu Y; Preis S; Geng X; Petit-Courty A; Kiechle M; Muckenhuber A; Dreyer T; Dorn J; Courty Y; Magdolen V
Mol Med; 2020 Feb; 26(1):19. PubMed ID: 32028882
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
